CTRI/2024/02/062634尚未招募2 期
Safety and efficacy of oral tofacitinib versus betamethasone oral mini-pulse therapy in the treatment of progressive non-segmental vitiligo: a pilot randomized clinical trial - NI
AIIMS, New Delhi0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •patients with rapidly progressive non segmental vitiligo with more than or equal to 5 new lesions in a month or more than or equal to 15 new lesions in 3 months
排除标准
- •1. Patients with segmental or stable or slowly progressive vitiligo
- •2. Pregnant or lactating females
- •3. Patients with known contraindictions to oral steroids or tofacitinib
- •4. Patients on topical treatment for last 2 weeks or systemic treatment for 4 weeks
- •5. Patients with latent tuberculosis infection not willing to take isoniazid preventive treatment
研究者
相似试验
尚未招募
Unknown
A clinical trial to Study the effects of oral tofacitinib and azathioprine in chronic actinic dermatitisCTRI/2023/03/051181Krishna Vishwa Vidyapeeth
尚未招募
Unknown
A comparison of efficacy and safety of oral tofacitinib vs methotrexate in management of moderate to severe chronic plaque psoriasisCTRI/2023/06/053443one
尚未招募
Unknown
Comparing effectiveness of oral Tofacitinib versus oral Cyclosporine in the treatment of prurigo nodularisCTRI/2024/07/071447IMS and SUM Hospital
尚未招募
4 期
sefulness of tofacitinib in atopic dermatitisCTRI/2024/08/072026AIIMS Bhubaneswar
招募中
3 期
A Clinical Trial to study effects of tofacitinib and oral mini pulse(betamethasone) in moderate to very severe alopecia areata patientsCTRI/2023/09/057476Arun Achar